Combined operation of distal renal, spleic venous shunt and disconnection for the treatment of congenital hepatic fibrosis in children;
远端脾肾静脉分流加断流术治疗小儿先天性肝纤维化
Congenital hepatic fibrosis: a clinicopathologic study of 7 cases;
先天性肝纤维化7例临床病理分析
Cirrhotic cardiomyopathy is one of the complications of liver cirrhosis which can be characterized by diastolic dysfunction,high cardiac output and decreased systemic vascular resistance.
肝硬化性心肌病是肝硬化的并发症之一,主要表现为心脏舒张功能减低、心排血量增加、全身血管阻力降低。
Cirrhotic cardiomyopathy is easily overlooked clinically often owing to the lack of clinical manifestations.
肝硬化可并发心功能不全,目前认为是肝硬化特有的一种并发症,即肝硬化性心肌病。
Cirrhotic cardiomyopathy is the term used to describe a constellation of features indicative of abnormal heart structure and function in patients with cirrhosis.
肝硬化患者出现心脏结构和功能异常,被称为肝硬化性心肌病。
Autoantibodies and Immunologic Function in Primary Biliary Cirrhosis: 20 Cases Analysis;
20例原发性胆汁性肝硬化自身抗体和免疫功能分析
Operation treatment of hepatolthiasis with biliary cirrhosis;
肝胆管结石并胆汁性肝硬化的手术处理
Study on variation of lipidemia and apolipoprotein in posthepatitic cirrhosis and biliary cirrhosis;
病毒性肝炎肝硬化与胆汁性肝硬化的血脂及载脂蛋白分析比较(英文)
Comparison on hematoblastic relevant parameter from patients with liver cirrhosis after heptitis B and patients with alcoholic cirrhosis;
乙型肝炎肝硬化与酒精性肝硬化患者血小板相关参数变化的比较
The effect of reduced glutathione on alcoholic cirrhosis and erythrocyte deformability;
还原型谷胱甘肽对酒精性肝硬化患者红细胞变形性的影响及疗效观察
The serum leptin in alcoholic cirrhosis and non-alcoholic fatty hepatic cirrhosis patients was obviously higher than that in hepatitis B cirrhosis and hepatitis C cirrhosis patients(P<0.
05);酒精性肝硬化组与非酒精性脂肪性肝硬化组相比较,瘦素水平无明显差异(P>0。
Clinical analysis of 12 cases of congenital hepatic fibrosis and literature review
先天性肝纤维化——附12例临床分析
The Gene Mapping and Linkage Analysis for Congenital Fibrosis of the Extraocular Muscles;
先天性眼外肌纤维化的基因定位与连锁分析
PHARMACODYNAMIC STUDY ON ANTI-EXPERIMENTAL HEPATIC FIBROSIS OF GANXIAN KELI
肝纤颗粒抗实验性肝纤维化药效学研究
Effects of salidroside on expression of ROCK in rats with liver fibrosis
红景天甙对肝纤维化大鼠肝组织ROCK表达的影响
Hepatic Chymase Content in Chronic Hepatitis Relationship to Fibrosis;
肝组织中Chymase浓度在慢性肝炎肝纤维化中的意义
The Evaluation of Efficacy of Yigan Kang Decoction on the Therapy of Hepatic Fibrosis in Patients with Chronic Hepatitis;
益肝康治疗慢性肝炎肝纤维化的临床疗效评估
Clinical research of Baoganning against liver fibrosis after chronic hepatitis B
保肝宁治疗慢性乙型肝炎肝纤维化的临床研究
THE EFFECTS OF RHODIOLA SACHALINENSIS A BOR ON THE ACTIVITES OF FIBROSIS-ASSOCIATED ENZYMES IN SERUM AND TISSUE IN RATS OF CCL_4-INDUCED LIVER FIBROSIS
红景天对大鼠血清和组织匀浆中肝纤维化相关酶活性的影响
An Experimental Study on Effects of HAS Against Hepatic Fibrosis in Rats
天胡荽有效成分HAS抗大鼠免疫性肝纤维化的实验研究
congenital afibrinogenemia
先天性纤维蛋白原缺乏症
The Relation between Fibrosis Marker of Patients with and Liver Cirrhosis
血清纤维化标志物与慢性肝炎患者肝纤维化关系的研究
Study on the correlation between serological indicators of hepatic fibrosis and PAPP and hepatic fibrosis
血清肝纤维化指标及PAPP指数与肝纤维化的相关性研究
A Chinese Familial and Sporadic Cases with Congenital Fibrosis of the Extraocular Muscles: Clinical and Molecular Genetic Study;
先天性眼外肌纤维化家系和散发患者临床及分子遗传学研究
Congenital Fibrosis of the Extraocular Muscles in Chinese Families: Clinical Phenotype, Linkage Mapping, and Mutation Identification of KIF21A;
先天性眼外肌纤维化家系连锁分析及KIF21A基因的突变检测
Linkage Analysis in Two Chinese Family with Congenital Fibrosis of Extraocular Muscles and Mutation Screening of Kif21A;
两个先天性广泛眼外肌纤维化家系的连锁分析及Kif21A基因突变研究
Objective: Observe the effect of Xiaozheng Kangxian (remove stasis and anti-fibrosis) Decoction (XZKXD) on the liver fibrosis of patients with chronic hepatitic (CH) Ⅱ.
目的：观察消症抗纤汤对慢性乙型肝炎（慢乙肝）患者肝纤维化的疗效。
Clinical Research on Hepatic Fibrosis Due to Chronic Hepatitis B Treated by AHF-I
抗肝纤Ⅰ号冲剂治疗慢性乙型肝炎肝纤维化的临床研究
The TCM Literature Study of Syndrome and Therapeutic Principles Research on Alcoholic Hepatic Fibrosis (Jiu Pi);
酒精性肝纤维化（酒癖）的中医文献研究